SecSonar.com

Stereotaxis, Inc. (STXS)

Stereotaxis, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Stereotaxis, Inc. (STXS) is a Medical - Instruments & Supplies company based in US with a market capitalization of $196M. Revenue grew 20.3% year-over-year and free cash flow was negative at -$13.8M. This page tracks STXS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 139 employees · IPO Aug 12, 2004

Valuation

Valuation & price

$1.85 · as of May 17, 2026 · -48.2% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

10.47

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$3.57$2.60$1.63Jul 25Dec 25Jul 26Jul 7, 25$2.14Jul 9, 25$2.21Jul 11, 25$2.25Jul 15, 25$2.25Jul 17, 25$2.38Jul 21, 25$2.23Jul 23, 25$2.28Jul 25, 25$2.25Jul 29, 25$2.46Jul 31, 25$2.27Aug 4, 25$2.29Aug 6, 25$2.25Aug 11, 25$2.54Aug 13, 25$2.70Aug 15, 25$2.73Aug 19, 25$2.88Aug 21, 25$2.84Aug 25, 25$2.76Aug 27, 25$2.87Aug 29, 25$2.88Sep 3, 25$2.71Sep 5, 25$2.90Sep 9, 25$2.89Sep 11, 25$2.88Sep 16, 25$2.79Sep 18, 25$2.80Sep 22, 25$2.88Sep 24, 25$2.93Sep 26, 25$2.94Sep 30, 25$3.11Oct 2, 25$3.04Oct 6, 25$3.30Oct 8, 25$3.57Oct 10, 25$3.07Oct 14, 25$3.05Oct 16, 25$3.03Oct 21, 25$3.05Oct 23, 25$3.10Oct 27, 25$3.05Oct 29, 25$2.92Oct 31, 25$2.91Nov 4, 25$2.70Nov 6, 25$2.68Nov 10, 25$2.79Nov 12, 25$2.43Nov 14, 25$2.22Nov 18, 25$2.29Nov 20, 25$2.24Nov 25, 25$2.47Nov 28, 25$2.46Dec 2, 25$2.25Dec 4, 25$2.43Dec 8, 25$2.36Dec 10, 25$2.37Dec 12, 25$2.37Dec 16, 25$2.38Dec 18, 25$2.32Dec 22, 25$2.45Dec 24, 25$2.43Dec 29, 25$2.30Jan 2, 26$2.32Jan 6, 26$2.55Jan 8, 26$2.58Jan 12, 26$2.56Jan 14, 26$2.75Jan 16, 26$2.68Jan 21, 26$2.75Jan 23, 26$2.67Jan 27, 26$2.53Jan 29, 26$2.33Feb 2, 26$2.21Feb 4, 26$2.09Feb 9, 26$2.12Feb 11, 26$2.03Feb 13, 26$1.99Feb 18, 26$2.03Feb 20, 26$2.07Feb 24, 26$2.10Feb 26, 26$2.21Mar 2, 26$2.22Mar 4, 26$2.20Mar 6, 26$2.05Mar 10, 26$1.97Mar 12, 26$1.88Mar 17, 26$1.89Mar 19, 26$1.82Mar 23, 26$1.84Mar 25, 26$1.86Mar 27, 26$1.82Mar 31, 26$1.84Apr 2, 26$1.87Apr 7, 26$1.85Apr 9, 26$1.95Apr 13, 26$1.92Apr 15, 26$2.01Apr 17, 26$2.03Apr 22, 26$1.94Apr 24, 26$1.93Apr 28, 26$1.86Apr 30, 26$1.87May 4, 26$1.90May 6, 26$1.92May 8, 26$1.90May 12, 26$1.92May 14, 26$1.94May 18, 26$1.78May 20, 26$1.85May 22, 26$1.92May 28, 26$2.08Jun 1, 26$1.94Jun 3, 26$1.84Jun 5, 26$1.78Jun 9, 26$1.85Jun 11, 26$1.82Jun 15, 26$1.84Jun 17, 26$1.78Jun 22, 26$1.87Jun 24, 26$1.63Jun 26, 26$1.68Jul 2, 26$1.78
$1.6252-week range$3.57
Loading valuation history…

Fundamentals

Key fundamentals

$196M

Market cap

20.3%

Revenue growth (YoY)

52.7%

Gross margin

-$13.8M

Free cash flow (USD)

-$8M

Net debt

Net cash position

6.8%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$32.2MFY 2017$31.1MFY 2018$29.3MFY 2019$28.9MFY 2020$26.6MFY 2021$35.0MFY 2022$28.1MFY 2023$26.8MFY 2024$26.9MFY 2025$32.4M
$32.2M$32.4M

Free cash flow by year

2016 → 2025

FY 2016$-7.0MFY 2017$-4.8MFY 2018$-2.8MFY 2019$-4.6MFY 2020$-3.6MFY 2021$-4.3MFY 2022$-10.8MFY 2023$-9.5MFY 2024$-8.5MFY 2025$-13.8M
-$7M-$13.8M

Gross margin by year

2021 → 2025

FY 202166.3%FY 202265.6%FY 202355.5%FY 202454.2%FY 202552.7%
66.3%52.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsMay 15, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • 8-K eventFirst Quarter Financial ResultsMay 12, 2026Filing
  • 8-K eventAcquisition AnnouncedApr 15, 2026Filing
  • Annual report10-K FiledApr 3, 2026Filing

Questions

Frequently asked questions

What is Stereotaxis, Inc.'s market cap?

Stereotaxis, Inc. (STXS) has a market capitalization of $196M.

What is STXS's P/E ratio?

A meaningful P/E ratio is not available for STXS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is STXS's price-to-book (P/B) ratio?

STXS trades at 10.47 times book value per share.

Are insiders buying STXS stock?

SEC Form 4 filings show no open-market insider buys at Stereotaxis, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Instruments & Supplies

INFU

InfuSystem Holdings, Inc.

$190.7M

KRMD

KORU Medical Systems, Inc.

$188.8M

SMTI

Sanara MedTech Inc.

$213.1M

UTMD

Utah Medical Products, Inc.

$213.6M

PDEX

Pro-Dex, Inc.

$214.6M

NYXH

Nyxoah S.A.

$112M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.